Evidence map›Paper›PMID 20526372›Full record

ArticlePloS one2010

Dynamics of lamin-A processing following precursor accumulation.

Qian Liu, Dae In Kim, Janet Syme, Phyllis LuValle, Brian Burke, Kyle J Roux

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Post-Translational Modification of Lamins: Mechanisms and Functions.Frontiers in cell and developmental biology · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Lamin A/C deficiency is an independent risk factor for cervical cancer.Cellular oncology (Dordrecht, Netherlands) · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Qian LiuDepartment of Histology and Embryology, Shandong University School of Medicine, Jinan, Shandong, China.
Dae In Kim
Janet Syme
Phyllis LuValle
Brian Burke
Kyle J Roux
University of Florida · USShandong University · CN

Funding

SUN-nesprin complexes in human laminopathiesR01GM084085 · NIGMS · UNIVERSITY OF FLORIDA · PI DUNN, WILLIAM A · 2008 to 2009
$608k
NIGMS NIH HHS R01 5R01GM084085-02NIGMS NIH HHS R01 GM084085
6 · The paper itself

Abstract

Lamin A (LaA) is a component of the nuclear lamina, an intermediate filament meshwork that underlies the inner nuclear membrane (INM) of the nuclear envelope (NE). Newly synthesized prelamin A (PreA) undergoes extensive processing involving C-terminal farnesylation followed by proteolysis yielding non-farnesylated mature lamin A. Different inhibitors of these processing events are currently used therapeutically. Hutchinson-Gilford Progeria Syndrome (HGPS) is most commonly caused by mutations leading to an accumulation of a farnesylated LaA isoform, prompting a clinical trial using farnesyltransferase inhibitors (FTI) to reduce this modification. At therapeutic levels, HIV protease inhibitors (PI) can unexpectedly inhibit the final processing step in PreA maturation. We have examined the dynamics of LaA processing and associated cellular effects during PI or FTI treatment and following inhibitor washout. While PI reversibility was rapid, with respect to both LaA maturation and associated cellular phenotype, recovery from FTI treatment was more gradual. FTI reversibility is influenced by both cell type and rate of proliferation. These results suggest a less static lamin network than has previously been observed.

Indexed as

Protein Processing, Post-TranslationalCell CycleCell Line, TumorHIV Protease InhibitorsHumansLamin Type ANuclear EnvelopeNuclear ProteinsOrganelle ShapePhenotypePrenylationProgeriaProtein PrecursorsTime FactorsHIV Protease InhibitorsLamin Type ANuclear Proteinsprelamin AProtein Precursors

Identifiers

PMID20526372
PMCPMC2878336
OpenAlexW2085821267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.